Evidence map›Paper›PMID 30125327›Full record

ArticlePloS one2018

Dysregulated expression of antioxidant enzymes in polyethylene particle-induced periprosthetic inflammation and osteolysis.

Kuo-Ti Peng, Meng-Hsueh Tsai, Chiang-Wen Lee, Yao-Chang Chiang, Pei-Chun Chen, Chun-Chieh Chen, Chih-Hsiang Chang, Hsin-Nung Shih, Pey-Jium Chang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Kuo-Ti PengDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Meng-Hsueh TsaiDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Chiang-Wen LeeDivision of Basic Medical Sciences, Department of Nursing, and Chronic Diseases and Health Promotion Research Center, Chang Gung Institute of Technology, Chiayi, Taiwan.
Yao-Chang ChiangCenter for Drug Abuse and Addiction, China Medical University Hospital, Taichung, Taiwan.
Pei-Chun ChenDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Chun-Chieh ChenDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan.
Chih-Hsiang ChangDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan.
Hsin-Nung ShihDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan.
Pey-Jium ChangGraduate Institute of Clinical Medical Sciences, College of Medicine, Chang-Gung University, Taoyuan, Taiwan.ORCID 0000-0002-6492-0346
Chang Gung Memorial Hospital · TWChang Gung University · TWChiayi Chang Gung Memorial Hospital · TWChang Gung University of Science and Technology · TWChina Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small wear particles (0.1-10 μm) in total joint replacement are generally considered as the major causative agent leading to periprosthetic inflammation and osteolysis. However, little is known about the roles of larger wear particles (10-100 μm) in periprosthetic inflammation and osteolysis. Additionally, although ample studies demonstrated that increased oxidative stress is critically involved in particle-induced inflammation and osteolysis, detailed changes in antioxidant enzymes expression in the disease development remain largely unclear. Herein, we used a rat knee prosthesis model to assess effects of polyethylene (PE) particles (20-60 μm) on the levels of oxidative stress markers such as malondialdehyde (MDA) and total antioxidant capacity (TAC) in blood plasma, and on the expression profiles of antioxidant enzymes in knee joint tissues. In combination with a forced-exercise intervention for all surgical rats, we found that the rat groups treated with both artificial joint and PE particles exhibited higher MDA levels and lower TAC levels, together with lower levels of physical activity and higher levels of inflammatory markers, than the sham group and the groups receiving artificial joint or PE particles alone at weeks 20-24 post-operatively. Dose-response relationships between the exposure to PE particles and the induction of oxidative stress and inflammation were also observed in the artificial joint/PE groups. Under such conditions, we unexpectedly found that most of antioxidant enzymes displayed pronounced up-regulation, with concomitant induction of inflammatory and osteoclast-inducing factors (including IL-1β, NF-κB and RANKL), in the artificial joint/PE groups as compared to the sham, artificial joint only, or PE only group. Only a few antioxidant enzymes including SOD2 and GPx2 showed down-regulation. Collectively, our findings demonstrate that implantation of artificial joint along with large PE particles synergistically trigger the induction of oxidative stress; however, down-regulation of many antioxidant enzymes may not necessarily occur during the disease development.

Indexed as

Bone-Implant InterfaceOxidative StressAnimalsGlutathione PeroxidaseImplants, ExperimentalInflammationInterleukin-1betaMaleMalondialdehydeNF-kappa BOsteoclastsOsteolysisParticle SizePolyethyleneRANK LigandRatsGlutathione Peroxidaseglutathione peroxidase 2, ratIL1B protein, ratInterleukin-1betaMalondialdehydeNF-kappa BPolyethyleneRANK LigandSuperoxide DismutaseSuperoxide Dismutase 2

Identifiers

PMID30125327
PMCPMC6101395
OpenAlexW2888695091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.